Halberd Corporation Alzheimer’s Disease Treatment Tests Yield Outstanding Results

By |2021-08-29T20:56:56-04:00August 30th, 2021|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 30, 2021 – Halberd Corp. (OTC PINK:HALB) provided an update on its Alzheimer’s Disease eradication experimentation being conducted at Youngstown State University (YSU) and Arizona State University (ASU).  Following standard scientific methodology, Halberd conducted two rounds of experimentation on Phosphorylated Tau, and the results were so astounding that the researchers want ...